![RemedyBio completes €10.5M financing from European Innovation Council](https://ala.associates/wp-content/uploads/2021/07/Remedy-Bio-Dan-Crowley.jpeg)
![RemedyBio completes €10.5M financing from European Innovation Council](https://ala.associates/wp-content/uploads/2021/07/Remedy-Bio-Dan-Crowley.jpeg)
![Genoskin launches ISR platform®, the first human skin ex vivo platform to study injection site reactions (ISR)](https://ala.associates/wp-content/uploads/2021/07/Subcutaneous-injection-TN-1080x675.jpg)
Genoskin launches ISR platform®, the first human skin ex vivo platform to study injection site reactions (ISR)
![Advent France Biotechnology appoints Sidonie Fabre as CFO](https://ala.associates/wp-content/uploads/2021/07/groupe-02-HD.png)
Advent France Biotechnology appoints Sidonie Fabre as CFO
Sidonie Fabre’s extensive career in finance will help Advent France Biotechnology (AFB) strengthen financial structure – as growing VC firm
![Oncodesign, Covalab, CheMatech and ABX-CRO launch DRIVE™-MRT, a premium complete, integrated service offer for radiopharmaceuticals drug discovery and generation](https://ala.associates/wp-content/uploads/2021/07/Science-Cover-Imaging.png)
Oncodesign, Covalab, CheMatech and ABX-CRO launch DRIVE™-MRT, a premium complete, integrated service offer for radiopharmaceuticals drug discovery and generation
![Yposkesi’s bioproduction ‘Boost’ project selected for France Relance scheme](https://ala.associates/wp-content/uploads/2021/06/logo_yposkesi-1080x675.jpg)
Yposkesi’s bioproduction ‘Boost’ project selected for France Relance scheme
![Ferrer launches third edition of Ferrer 4 Future program](https://ala.associates/wp-content/uploads/2021/06/F4F-Header-pdf-1080x675.jpg)
Ferrer launches third edition of Ferrer 4 Future program
![Yposkesi launches construction of its second commercial bioproduction site](https://ala.associates/wp-content/uploads/2021/06/CAM01NEW-1-1080x675.jpg)
Yposkesi launches construction of its second commercial bioproduction site
Yposkesi’s bioproduction Boost project awarded €1.2M in French government funding
![Advent France Biotechnology appoints Sidonie Fabre as CFO](https://ala.associates/wp-content/uploads/2021/06/Sidonie-Fabre-853x675.png)
Advent France Biotechnology appoints Sidonie Fabre as CFO
![Tollys presents scientific data supporting preclinical proof of concept for TL-532, its cancer immunotherapy drug candidate](https://ala.associates/wp-content/uploads/2021/06/EACR-STING-1080x675.png)